Columbia University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Columbia University sits in the top decile of US sponsors by registered trial count (#34 of 15,742 sponsors by registered trial count).
Columbia University: 958 sponsored US clinical trials, 171 recruiting.
Columbia University sponsors 958 registered US clinical trials on ClinicalTrials.gov, 171 of them currently recruiting, and 597 completed. 88 of these trials are in Phase 3-4 (later-stage) and 191 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 9 trials.
Top-decile sponsor footprint
Columbia University ranks in the top decile of sponsors by registered trial count (#34 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
597 of 736 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
958 total, page 4 of 20
Longitudinal Study of Neurogenetic Disorders
NCT03492060
Brace Monitoring for Adolescent Idiopathic Scoliosis (AIS)
NCT03292601
Genes and Environment in Multiple Sclerosis
NCT01353547
Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma
NCT03127774
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
NCT03135886
Late Onset Alzheimer's Disease
NCT05010603
Genetic Studies of Early-onset Dementia
NCT04906863
Tissue Repository: CTCL Collection Protocol
NCT02840747
Physical Activity and Cognitive Development in Children
NCT02542683
Gastric Emptying in Neonates and Infants After Formula Feeding
NCT02665923
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
NCT02602769
Study to Investigate Genetic Causes of Severe Early Childhood Onset Obesity.
NCT01998750
Evaluation of Post-PACU Pain Management in Pediatric Surgery
NCT02352116
The Natural History Study of Mitochondrial NeuroGastroIntestinal Encephalopathy (MNGIE)
NCT01694953
North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)
NCT01694940
Allergy and Immunology Natural History Study
NCT05584488
Pancreatic Cancer Genetics
NCT01102569
Study on Basal Joint Arthritis Prospective
NCT01376024
Diaphragmatic Hernia Research & Exploration, Advancing Molecular Science
NCT00950118
PANCREATIC DISEASE COHORT A Registry and Biospecimen Bank to Better Understand Pancreatic Disease
NCT01102556
Natural History Study - Mitochondrial Disease
NCT01532791
The Sleep2BWell Trial
NCT06565104
Living Healthy for Moms RCT
NCT06666400
HPV Vaccine Reminders - SEARCH II Study
NCT06161831
Young Adults With Violent Behavior During Early Psychosis (Aim 2)
NCT05756855
Mother-infant Bonding During COVID-19
NCT04531618
Integrated Care and Treatment for Severe Infectious Diseases and Substance Use Disorders Among Hospitalized Patients
NCT05688423
Implementing a Home Blood Pressure Monitoring Program in Primary Care
NCT05885997
TeleMAb Retrospective Cohort Study
NCT07405294
Effect of Rapamycin in Ovarian Aging
NCT05836025
CT for Personalized Mechanical Ventilation
NCT05977153
Nicotinamide and Pyruvate for Open Angle Glaucoma: A Randomized Clinical Study
NCT05695027
Trial of Crisis Intervention Team (CIT) Mental Health Training for Police Officers
NCT05606289
Alpha-1 Antitrypsin Disease Cohort: Longitudinal Biomarker Study of Disease
NCT05297812
CAMP Air: Efficacy and Cost-effectiveness in Urban Adolescents
NCT05091034
ARMOR-Household: Characterizing Transmission of COVID-19 in Households of SARS-CoV-2 Index Cases
NCT05467917
TREAT to Improve Cardiometabolic Health
NCT04465721
A Prospective Natural History Study in Uveal Melanoma
NCT04588662
Metformin in Alzheimer's Dementia Prevention
NCT04098666
Romosozumab/Denosumab Study for Premenopausal IOP
NCT04800367
Eating Behaviors in Shift Workers
NCT04468672
Genentech Validation Tool for Pulmonary Fibrosis
NCT04676594
Study of Rituximab or Tocilizumab for Patients With Steroid-Dependent Immune-Related Adverse Events (irAEs)
NCT04375228
Integrated HIV Prevention and HCV Care for PWID
NCT03981445
Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)
NCT04271709
A Study of Combination Spartalizumab and Canakinumab in Patients With Localized Clear Cell Renal Cell Carcinoma
NCT04028245
18F-DCFPyL Positron Emission Tomography (PET)/Computed Tomography (CT) in Men With Prostate Cancer
NCT03824275
Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Pheochromocytoma/Paraganglioma
NCT03839498
Prostate Cancer Monitoring Using [18F]DCFPyL and Blood Based Biomarkers
NCT03585114
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial - Hemodynamics (CREST-H)
NCT03121209
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 86 |
| Phase 2 | 105 |
| Phase 3 | 23 |
| Phase 4 | 65 |
Therapeutic Areas
What is open in the Columbia University pipeline
171 recruiting of 958 indexed (18% open); 597 completed (62%).
Phase mix: 88 late (III/IV) vs 191 early (I/II) (early-phase heavy).
Top condition: Obesity (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Columbia University: open-pipeline peers nationwide
Peers matched on 958 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Columbia University sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 958 trials (± recruiting share)
- University of Minnesota · 966 trials · 19% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- University of California, Los Angeles · 897 trials · 18% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Kite, A Gilead Company · 18% recruiting · 28 trials
- Mirum Pharmaceuticals · 18% recruiting · 28 trials
- West Virginia University · 18% recruiting · 122 trials
- Hospital for Special Surgery, New York · 18% recruiting · 194 trials
Related
What to do with this Columbia University page
958 registered trials is a research-attention snapshot, not an endorsement of Columbia University or any single study.
- 171 of Columbia University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Columbia University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Columbia University pipeline card: 958 registered trials from official public datasets.Report a data error.